Question: Has this approved drug been withdrawn due to toxicity reasons for all indications, populations, and doses in at least one country (not necessarily the US)?
Constraint: The Compound has the SMILES CN1CCN(c2ccc(N3C[C@H](CO)OC3=O)cc2F)C=N1.
Answer: No
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CN1CCN(c2ccc(N3C[C@H](CO)OC3=O)cc2F)C=N1
CN1CCN(c2ccc(N3C[C@H](CO)OC3=O)cc2F)C=N1
(5R)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
Has this approved drug been withdrawn due to toxicity reasons for all indications, populations, and doses in at least one country (not necessarily the US)?
No